Analysis of plasma hemostasis and the role of microvesicles in the coagulation process in patients with COVID-19
- Authors: Gracheva E.S.1, Abdullina R.R.1, Mustafin I.G.1, Abdulganieva D.I.1
-
Affiliations:
- Kazan State Medical University
- Issue: Vol 105, No 6 (2024)
- Pages: 917-925
- Section: Theoretical and clinical medicine
- URL: https://journals.rcsi.science/kazanmedj/article/view/311377
- DOI: https://doi.org/10.17816/KMJ633994
- ID: 311377
Cite item
Abstract
BACKGROUND: Coagulopathies in COVID-19 are an important aspect in the pathophysiological mechanisms, clinical picture of the disease, and occurrence of delayed complications.
AIM: To study plasma hemostasis using turbidimetry, thromboelastography, and the role of microvesicles in the coagulation process in patients with COVID-19.
MATERIAL AND METHODS: The study used blood samples from patients of the temporary infectious diseases hospital based on the State Autonomous Healthcare Institution “Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan” in Kazan (n=213) in the period from June to August 2020. Patients were divided into two groups according to the severity of the disease: the first group — moderate COVID-19 (n=138), the second group — severe COVID-19 (n=75). Patients were treated according to the protocols of the Temporary Methodological Recommendations of the Ministry of Health of the Russian Federation, version 7. The blood of healthy donors (n=20) was used as a control group. Plasma hemostasis was assessed using dynamic turbidimetry (measured lag period — Lag, polymerization rate — V, maximum optical density at a given wavelength — Amax) and thromboelastography (determined coagulation activation time — R). Statistical processing of the results was performed using IBM SPSS Statistics 26.0. The groups were compared using the nonparametric Mann–Whitney U-test. Statistical processing of the results following standart normal distribution was performed using the Student's t-test. Differences were considered significant at p <0.05.
RESULTS: Severe COVID-19 was characterized by an increase in the lag period (9.4±0.8 min relative to the control 6.2±1.2 min; p <0.0001), a decrease in the polymerization rate (1.12±0.71 OD units/s relative to the control 3.93±2.3 OD units/s; p <0.0001) and a decrease in the maximum optical density of the clot (0.576±0.17 OD units relative to the control 1.625±0.433 OD units; p <0.0001). In moderate cases, a shortening of the lag period was noted (3.8±1.1 min relative to the control 6.2±1.2 min; p=0.0004), the maximum optical density of the clot was lower than the control (1.412±0.351 OD units at 1.625±0.433 OD units, respectively; p=0.0007). In patients with moderate disease severity, a 1.6-fold reduction in coagulation activation time was noted relative to the control group. In patients with severe disease, coagulation activation time was increased by 1.5 times relative to the control. After adding microvesicles to the samples, this parameter decreased by 2.12 times in patients with a moderate course of the disease (16.9±1.1 min and 8±0.6 min; p <0.0001), and by 1.44 times in patients with a severe course of the disease (10.8±0.9 min and 7.5±0.5 min; p <0.0001).
CONCLUSION: Moderate COVID-19 is characterized by signs of hypercoagulation, which can lead to the development of thrombotic complications; severe disease is accompanied by hypocoagulation, which contributes to hemorrhagic complications.
Full Text
##article.viewOnOriginalSite##About the authors
Elena S. Gracheva
Kazan State Medical University
Author for correspondence.
Email: Gracheva020688@mail.ru
ORCID iD: 0000-0002-8543-6529
SPIN-code: 3290-5459
Postgrad. Stud., Assist., Depart. of Biochemistry and Clinical Laboratory Diagnostics
Russian Federation, KazanRufina R. Abdullina
Kazan State Medical University
Email: rufina.abdullina.r@mail.ru
ORCID iD: 0009-0000-5975-4390
SPIN-code: 7099-8375
Assist., Depart. of Biochemistry and Clinical Laboratory Diagnostics
Russian Federation, KazanIl’shat G. Mustafin
Kazan State Medical University
Email: ilshat.mustafin@kazangmu.ru
ORCID iD: 0000-0001-9683-3012
SPIN-code: 1588-6988
MD, D. Sci. (Med.), Prof., Head of Depart., Depart. of Biochemistry and Clinical Laboratory Diagnostics
Russian Federation, KazanDiana I. Abdulganieva
Kazan State Medical University
Email: diana-s@mail.ru
ORCID iD: 0000-0001-7069-2725
SPIN-code: 6676-4270
MD, D. Sci. (Med.), Prof., Head of Depart., Depart. of Hospital Therapy
Russian Federation, KazanReferences
- Baklaushev VP, Kulemsin SВ, Gorchakov АА, Lesnyak VN, Yusubalieva GМ, Sotnikova АG. COVID-19. Etiology, pathogenesis, diagnosis and treatment. Journal of Clinical Practice. 2020;11(1):7–20. (In Russ.) doi: 10.17816/clinpract26339
- Wang D, Hu B, Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585
- Roitman EV, Vavilova TV, Markin SM, Kravtsov PF, Mazayshvili KV. The realities of the anticoagulant therapy using in COVID-19. Tromboz, Gemostaz i Reologiya. 2021;(1):18–25. (In Russ.) doi: 10.25555/THR.2021.1.0957
- Kolesnikov VV. Roitman EV, Leonov AA. Anticoagulant treatment for severe COVID-19 with high bleeding risk. Tromboz, Gemostaz i Reologiya. 2022;(1):59–68. (In Russ.) doi: 10.25555/THR.2022.1.1010
- Shatohin YuV, Snezhko IV, Ryabikina EV. Violation of hemostasis in coronavirus infection. South Russian Journal of Therapeutic Practice. 2021;2(2):6–15. (In Russ.) doi: 10.21886/2712-8156-2021-2-2-6-15
- Yokota S, Kuroiwa E, Nishioka K. Novel coronavirus disease (COVID-19) and cytokine storms. For more effective treatments from the viewpoints of an inflammatory pathophysiology perspective. Infectious diseases: news, opinions, training. 2020;9(4):13–25. doi: 10.33029/2305-3496-2020-9-4-13-25
- Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967;13(3):269–288. doi: 10.1111/j.1365-2141.1967.tb08741.x
- Zubairov DM, Zubairova LD. Mikrovezikuly v krovi: funktsii i ikh rol' v tromboobrazovanii. (Microvesicles in the blood: functions and their role in thrombus formation.) Moscow: GEOTAR-MED; 2009. 167 p. (In Russ.)
- Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–1742. doi: 10.1111/jth.14850
- Hippensteel JA, Burnham EL, Jolley SE. Prevalence of venous thromboembolism in critically ill patients with COVID-19. Br J Haematol. 2020;190(3):e134–e137. doi: 10.1111/bjh.16908
- Khismatullin RR, Ivaeva RA, Abdullayeva S, Shakirova AZ, Khuzin FF, Kiassov AP, Litvinov RI. Pathological manifestations of inflammatory microthrombosis in COVID-19. Kazan Medical Journal. 2022;103(4):575–586 (In Russ.) doi: 10.17816/KMJ2022-575
- Hamali HA, Saboor M, Dobie G, Madkhali AM, Akhter MS, Hakamy A, Al-Mekhlafi HM, Jackson DE, Matari YH, Mobarki AA. Procoagulant microvesicles in COVID-19 patients: Possible modulators of inflammation and prothrombotic tendency. Infect Drug Resist. 2022;15:2359–2368. doi: 10.2147/IDR.S355395
- Nieri D, Neri T, Petrini S, Vagaggini B, Paggiaro P, Celi A. Cell-derived microparticles and the lung. Eur Respir Rev. 2016;25(141):266–277. doi: 10.1183/16000617.0009-2016
- Guervilly C, Bonifay A, Burtey S, Sabatier F, Cauchois R, Abdili E, Arnaud L, Lano G, Pietri L, Robert T, Velier M, Papazian L, Albanese J, Kaplanski G, Dignat-George F, Lacroix R. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv. 2021;5(3):628–634. doi: 10.1182/bloodadvances.2020003308
- Sirotkina OV, Ermakov AI, Zhilenkova YI, Zolotova EA, Kudlay DA, Vavilova TV, Gaykovaya LB. Dynamics of microvesicle formation in blood in patients with COVID-19 at different stages of the disease. Preventive and clinical medicine. 2021;81(4):68–74 (In Russ.) doi: 10.47843/2074-9120_2021_4_68
- Yarets YI. Tromboehlastografiya: osnovnye pokazateli, interpretatsiya rezul'tatov. (Thromboelastography: main indicators, interpretation of results.) Gomel: State Institution “RNPC RMiEH”; 2018. 26 p. (In Russ.)
- Nabiullina RM, Mustafin IG, Ataullakhanov FI, Litvinov RI, Zubairova L.D. Thrombin-mediated effects of blood microparticles on formation, structure, and stability of fibrin clots. IM Sechenov Russian Journal of Physiology. 2015;101(7):812–821. (In Russ.) EDN: UABUTT
Supplementary files
